Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-17

Clinical Trial Update: Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes [NA]

View source ↗

Summary

This clinical trial update describes a study of cyclophosphamide for associated acquired lipodystrophy syndrome in patients with type 1 diabetes mellitus, which…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Lipodystrophy Acquired, Type1diabetes | NA | Status: ACTIVE_NOT_RECRUITING